Urgent action to tackle antimicrobial resistance must take account of all the scientific opportunities available, find new resources to support academia and emphasize the importance of innovation to policy-makers and to the general public.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Inhibiting the two-component system GraXRS with verteporfin to combat Staphylococcus aureus infections
Scientific Reports Open Access 21 October 2020
-
Measuring and mapping the global burden of antimicrobial resistance
BMC Medicine Open Access 04 June 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fears, R. & ter Meulen, V. What do we need to do to tackle antimicrobial resistance? Lancet Global Health 2, e11–e12 (2014).
Acknowledgements
We thank all who contributed to the discussion in Hannover in March 2014.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
van der Meer, J., Fears, R., Davies, D. et al. Antimicrobial innovation: combining commitment, creativity and coherence. Nat Rev Drug Discov 13, 709–710 (2014). https://doi.org/10.1038/nrd4448
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4448
This article is cited by
-
Inhibiting the two-component system GraXRS with verteporfin to combat Staphylococcus aureus infections
Scientific Reports (2020)
-
Measuring and mapping the global burden of antimicrobial resistance
BMC Medicine (2018)